Panacea Biotec Ltd.
NSE: PANACEABIO | BSE: 531349
₹418.55
₹-5.75
(-1.36%)
As on 22-May-2026IST
Market cap
₹2,565 Cr
Revenue (TTM)
₹606 Cr
P/E Ratio
--
P/B Ratio
3.1
Div. Yield
0 %
Quality Score
3/10
Growth Score
5/10
Valuation Score
3/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-8 Cr
-
ROE
-1 %
-
ROCE
-0.5 %
-
Industry P/E
31.45
-
EV/EBITDA
-224.4
-
Debt to Equity
0
-
Book Value
₹135.6
-
EPS
₹-216.8
-
Face value
1
-
Shares outstanding
61,250,746
10 Years Aggregate
CFO
₹-34.33 Cr
EBITDA
₹55.21 Cr
Net Profit
₹577.53 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Panacea Biotec
| 11.2 | 23.8 | 22.6 | -17.5 | 52.0 | 2.4 | 20.2 |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Panacea Biotec
| -14.4 | 142.3 | 18.2 | -28.5 | -16.5 | 84.2 | -17.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Panacea Biotec
|
418.6 | 2,565.2 | 605.6 | -8.2 | -11.2 | -159.9 | -- | 3.1 |
| 3,107.5 | 38,804.4 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.7 | 8.6 | |
| 8,587.5 | 21,510.6 | 2,177.5 | 200.9 | 11.3 | 26.5 | 107.1 | 25.9 | |
| 2,028.0 | 15,420.9 | 2,187.2 | 649.7 | 31.5 | 19 | 24 | 4.3 | |
| 1,343.8 | 18,628.3 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.1 | 4.8 | |
| 2,192.6 | 35,263.5 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.7 | 8.5 | |
| 4,670.8 | 21,395.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.6 | 5.1 | |
| 5,553.0 | 9,231.7 | 1,348.5 | 293.5 | 28.1 | 50.7 | 31.5 | 13.2 | |
| 490.3 | 9,644.1 | 1,538.1 | 226.2 | 20.4 | 9 | 39.6 | 3.7 | |
| 1,153.2 | 10,628.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Danish Khanna
Companies that have Attracted Institutions
1 min read•By Vikas Vardhan
About Panacea Biotec
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates... through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, Mpox, and hepatitis A vaccines etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India. Read more
-
Incorporated
1984
-
Chairman
Rajesh Jain
-
Managing Director
Rajesh Jain
-
Group
Soshil Kumar Jain
-
Headquarters
Lalru, Punjab
-
Website
Looking for more details about Panacea Biotec Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Panacea Biotec
What is the current share price of Panacea Biotec Ltd Today?
The share price of Panacea Biotec Ltd is ₹418.55 (NSE) and ₹418.80 (BSE) as of 22-May-2026 IST. Panacea Biotec Ltd has given a return of 51.99% in the last 3 years.
What is the current PB & PE ratio of Panacea Biotec Ltd?
Since, TTM earnings of Panacea Biotec Ltd is negative, P/E ratio is not available.
The P/B ratio of Panacea Biotec Ltd is 3.09 times as on 22-May-2026, a 33 discount to its peers’ median range of 4.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
3.23
|
|
2024
|
0.00
|
0.88
|
|
2023
|
0.00
|
0.79
|
|
2022
|
0.84
|
1.04
|
|
2021
|
0.00
|
-4.75
|
What is the 52 Week High and Low of Panacea Biotec Ltd?
The 52-week high and low of Panacea Biotec Ltd are Rs 549.70 and Rs 292.40 as of 23-May-2026.
What is the market cap of Panacea Biotec Ltd?
Panacea Biotec Ltd has a market capitalisation of ₹ 2,565 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Panacea Biotec Ltd?
Before investing in Panacea Biotec Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.